
Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug
- This approval for XPOVIO® in combination with bortezomib and dexamethasone (XVd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therap...
- July 28, 2025 08:49 PM AEST
- Cision

2025 World Internet Conference Digital Silk Road Development Forum Opens in Quanzhou
QUANZHOU, China, July 28, 2025 /PRNewswire/ -- A news report from CRI Online: The opening ceremony of the Digital Silk Road Development Forum of the 2025 World Internet Conference On July 24, 20...
- July 28, 2025 08:45 PM AEST
- Cision

STRATEGIC PARTNERSHIP BETWEEN SETIA AWAN & COBNB TO UNLOCK INVESTOR VALUE AT ASTRUM AMPANG
Introducing a tenancy-backed model for ready rental income PETALING JAYA, Malaysia, July 28, 2025 /PRNewswire/ -- Setia Awan Group (SAG) has entered into a strategic collaboration with COBNB Mal...
- July 28, 2025 08:43 PM AEST
- Cision

OneConnect International CTO at Fortune Brainstorm AI: Future of Finance Demands Hybrid AI Approach for Trust and Control
SINGAPORE, July 28, 2025 /PRNewswire/ -- The future of artificial intelligence in finance lies in a hybrid approach that combines the generative power of large models with the precision of traditional...
- July 28, 2025 08:41 PM AEST
- Cision

Interventional Robot's RCT Research Published in JNIS, a Leading Journal in Neurointervention!
SHANGHAI, July 28, 2025 /PRNewswire/ -- The multicenter, randomized controlled trial (RCT) results of the PANVIS-A® NeuroInterventional Robotic System—led by Professor Liu Jianmin (Changhai H...
- July 28, 2025 08:35 PM AEST
- Cision

SuperX Announces Plan for the Establishment of its AI Supply Center in Japan to Accelerate End-to-End Solution Delivery
The new hub will serve as a regional center for the integration and delivery of SuperX's core AI Server and HVDC products, with a projected annual capacity of 10,000 high-performance AI servers...
- July 28, 2025 08:30 PM AEST
- Cision

Quhuo Partners with NIU World to Launch Innovative Fresh Beef Chain Brand Incubation Platform, Accelerating the Transformation of China's Fresh Beef Consumption Market
BEIJING, July 28, 2025 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"), a leading tech-enabled service platform, today announced a strategic partnership...
- July 28, 2025 08:00 PM AEST
- Cision

Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 B...
- July 28, 2025 08:00 PM AEST
- Cision

DIFC's H1 2025 results fuel Dubai's economic vision (D33) and demonstrate global leadership in financial services and innovation
DUBAI, UAE, July 28, 2025 /PRNewswire/ -- Dubai International Financial Centre (DIFC), the leading global financial centre in the Middle East, Africa and South Asia (MEASA), announced its best-ever pe...
- July 28, 2025 07:57 PM AEST
- Cision

Caliway Announces FDA Clearance of IND Application for CBL-514 to Proceed with SUPREME-01, the First Global Pivotal Phase 3 Study for Reducing Abdominal Subcutaneous Fat
CBL-514, Caliway's first-in-class lipolysis drug candidate, has been granted clearance from the U.S. FDA to proceed with SUPREME-01, a global, multicenter, pivotal Phase 3 study. Subject recru...
- July 28, 2025 07:51 PM AEST
- Cision